Exclusive

EXCLUSIVE: Nigerian “Dr.” Guilty of Sexual Misconduct Toward a Minor, Allowed to Practice in Alberta

Regina “Dr.” accused of multiple sexual assaults and impropriety, Imafidon “Thomas” Izekor was found guilty of two counts of sexual misconduct, one involving a 16-year-old minor and another involving a 19-year-old patient, and is currently suspended in Saskatchewan Despite his suspension, the College of Physicians and Surgeons of Alberta (CPSA) continues to allow him to see female patients, in contrast to Saskatchewan’s medical board, which deemed him a risk and required him to demonstrate rehabilitation before resuming practice.

Video report: EXCLUSIVE: Nigerian “Dr.” Guilty of Sexual Misconduct Toward a Minor, Allowed to Practice in Alberta

Regina “Dr.” accused of multiple sexual assaults and impropriety, Imafidon “Thomas” Izekor was found guilty of two counts of sexual misconduct, one involving a 16-year-old minor and another involving a 19-year-old patient, and is currently suspended in Saskatchewan



Despite his suspension, the College of Physicians and Surgeons of Alberta (CPSA) continues to allow him to see female patients, in contrast to Saskatchewan’s medical board, which deemed him a risk and required him to demonstrate rehabilitation before resuming practice.


I went to Edmonton’s Northgate Medical Clinic to ask whether “Dr.” Imafidon is still asking minors out for dinner, telling them not to inform their parents, and lecturing them that they need an “older guy” to take care of them. What I found out was concerning.


In 2014, the Texas Medical Board issued an order against Imafidon requiring him to stop falsely advertising himself as a “doctor” in Texas. “Dr.” Imafidon’s case is another example of weak federal and provincial medical-board oversight, particularly when it comes to misrepresentation and fraud by foreign graduates claiming to be “doctors.”



MB
Get our stories the moment we publish them.Media Bezirgan is free on iPhone.
Download on the App Store
Keep this reporting online

Help cover legal risk, travel, and fees to obtain court and regulatory records.

Donate
Newsletter

Get our next investigation by email

We’ll email you when we publish. No spam; unsubscribe anytime.

Newsletter

Get our investigations by email

We’ll email you when we publish. No spam; unsubscribe anytime.